Analytic validation of a clinical circulating tumor DNA assay for patients with solid tumors.
2016
e23049Background: With an increasing number of circulating tumor DNA (ctDNA) profiling assays available, physicians must be empowered to distinguish which assays have the high level of accuracy req...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI